Industry News
Engineers Develop A Tiny, Implantable Medical Device That Can Propel Itself Through The Bloodstream
Feb 23, 2012
Someday, your doctor may turn to you and say, "Take two surgeons and call me in the morning." If that day arrives, you may just have Ada Poon to thank... Read More
Researchers Discover New Member Of The Breast-Cancer Gene Network
Feb 23, 2012
The infamous BRCA genes do not act alone in causing cancer; there is a molecular syndicate at work preventing the way cells normally repair breaks in DNA that is at the root of breast cancer. But finding all of the BRCA molecular collaborators has been elusive... Read More
Engineers Develop A Tiny, Implantable Medical Device That Can Propel Itself Through The Bloodstream
Feb 23, 2012
Someday, your doctor may turn to you and say, "Take two surgeons and call me in the morning." If that day arrives, you may just have Ada Poon to thank... Read More
Median Survival Time Nearly Doubled By Newly Approved Drug For Metastatic Melanoma
Feb 23, 2012
Researchers from UCLA's Jonsson Comprehensive Cancer Center, together with scientists from 12 other sites in the United States and Australia, report for the first time that a newly approved drug for patients with metastatic melanoma nearly doubles median survival times, a finding that will change the way this deadly form of skin cancer is treated... Read More
Why Children With Down Syndrome Have Increased Leukemia Risk
Feb 23, 2012
Children with Down syndrome (DS) have an increased risk of developing leukemia, in particular acute megakaryoblastic leukemia (AMKL) and acute lymphoblastic leukemia (ALL). Through their studies in a mouse model of DS, a team of researchers led by John Crispino, at Northwestern University, Chicago, has now identified a potential explanation as to why children with DS are at increased risk of AMKL... Read More
Among People With Health Insurance, The Recession And High Co-Pays Tied To Fewer Colonoscopy Screenings
Feb 23, 2012
The recent U.S. economic recession was the longest and most severe since World War II. During this period, personal spending on health care grew at the slowest rate in over 50 years, suggesting that Americans used less health care. A new study finds that these cut backs were not limited to Americans who lost their health insurance, nor restricted to unnecessary services... Read More
Median Survival Time Nearly Doubled By Newly Approved Drug For Metastatic Melanoma
Feb 23, 2012
Researchers from UCLA's Jonsson Comprehensive Cancer Center, together with scientists from 12 other sites in the United States and Australia, report for the first time that a newly approved drug for patients with metastatic melanoma nearly doubles median survival times, a finding that will change the way this deadly form of skin cancer is treated... Read More
Why Children With Down Syndrome Have Increased Leukemia Risk
Feb 23, 2012
Children with Down syndrome (DS) have an increased risk of developing leukemia, in particular acute megakaryoblastic leukemia (AMKL) and acute lymphoblastic leukemia (ALL). Through their studies in a mouse model of DS, a team of researchers led by John Crispino, at Northwestern University, Chicago, has now identified a potential explanation as to why children with DS are at increased risk of AMKL... Read More
Among People With Health Insurance, The Recession And High Co-Pays Tied To Fewer Colonoscopy Screenings
Feb 23, 2012
The recent U.S. economic recession was the longest and most severe since World War II. During this period, personal spending on health care grew at the slowest rate in over 50 years, suggesting that Americans used less health care. A new study finds that these cut backs were not limited to Americans who lost their health insurance, nor restricted to unnecessary services... Read More
A Breakthrough In Understanding The Biology And Treatment Of Ovarian Cancer
Feb 23, 2012
Researchers at The Pennsylvania State University College of Medicine, Hershey, Pennsylvania have discovered that the presence and integrity of the opioid growth factor receptor (OGFr), which mediates the inhibitory action of opioid growth factor (OGF) on cell proliferation, is a key to understanding the progression and treatment of human ovarian cancer... Read More
Previous Page Next Page